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Abstract
Background: DNA vaccination is a convenient means of immunizing animals with recombinant
parasite antigens. DNA delivery methods are believed to affect the qualitative nature of immune
responses to DNA vaccines in ways that may affect their protective activity. However, relatively
few studies have directly compared immune responses to plasmids encoding the same antigens
after injection by different routes. Therefore, the purpose of this study was to explore the influence
of the route of administration on antibody responses to plasmids encoding antigens from the filarial
nematode parasite Brugia malayi.
Methods: Four B. malayi genes and partial genes encoding paramyosin (BM5), heat shock protein
(BMHSP-70), intermediate filament (BMIF) and a serodiagnostic antigen (BM14) were inserted in
eukaryotic expression vectors (pJW4303 and pCR™3.1). BALB/c mice were immunized with
individual recombinant plasmids or with a cocktail of all four plasmids by intramuscular injection
(IM) or by gene gun-intradermal inoculation (GG). Antibody responses to recombinant antigens
were measured by ELISA. Mean IgG1 to IgG2a antibody ratios were used as an indicator of Th1 or
Th2 bias in immune responses induced with particular antigens by IM or GG immunization. The
statistical significance of group differences in antibody responses was assessed by the non-
parametric Kruskal-Wallis test.
Results: Mice produced antibody responses to all four filarial antigens after DNA vaccination by
either the IM or GG route. Antibody responses to BM5 paramyosin were strongly biased toward
IgG1 with lower levels of IgG2a after GG vaccination, while IM vaccination produced dominant
IgG2a antibody responses. Antibody responses were biased toward IgG1 after both IM and GG
immunization with BMIF, but antibodies were biased toward IgG2a after IM and GG vaccination
with BMHSP-70 and BM14. Animals injected with a mixture of four recombinant plasmid DNAs
produced antibodies to all four antigens.
Conclusions: Our results show that monovalent and polyvalent DNA vaccination successfully
induced antibody responses to a variety of filarial antigens. However, antibody responses to
different antigens varied in magnitude and with respect to isotype bias. The isotype bias of antibody
responses following DNA vaccination can be affected by route of administration and by intrinsic
characteristics of individual antigens.
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Background
Brugia malayi is a mosquito-borne nematode parasite and
a cause of lymphatic filariasis in humans [1]. The parasite
is transmitted when third stage larvae (L3) of B. malayi
enter the human host following a bite by an infective mos-
quito. Control is based on treatment of microfilaria (MF)
carriers and anti-mosquito measures that decrease trans-
mission; no vaccines are available for prevention of
infection.
Prior studies have shown that a degree of protective
immunity to filariasis can be induced in animals by vacci-
nation with irradiated L3 [2,3]. The potential for use of
live filariasis vaccines in humans is limited because of
safety issues and limited availability of larvae. Several lab-
oratories are working to develop effective recombinant
antigen-based vaccines that would be more practical and
effective than live parasite vaccines.
DNA vaccination is a promising approach that may have
advantages over vaccination with live parasites or protein
antigens. DNA vaccines have been shown to be an effec-
tive means of generating cellular and humoral immune
responses, and they have conferred protection against a
wide range of infectious agents including viruses, para-
sites, and bacteria in animal models (reviewed in [4]).
We have previously reported that vaccination with recom-
binant B. malayi paramyosin (BM5) protein induced par-
tial immunity to challenge infections in jirds [5]. More
recently, we reported that mice injected IM with plasmid
DNA encoding BM5 developed antigen-specific humoral
and cellular immune responses [6]. However, this vacci-
nation failed to protect jirds from challenge infections.
These results raised the issue of how to optimize DNA vac-
cination to induce protective immunity.
Considerable effort has been expended toward improving
the efficacy of DNA vaccines through vector design, opti-
mization of immunization schedules, and by combining
DNA vaccination with other vaccine types (reviewed in
[7]). The most widely used DNA vaccination methods are
intramuscular injection of plasmid DNA in an aqueous
solution (IM) and ballistic intradermal injection of plas-
mid DNA-coated gold particles by gene gun (GG). Intra-
muscular injection and gene gun inoculation differ in the
efficiency of DNA delivery [8,9]. Following IM injection,
cells take up DNA from the extracellular space by poorly
understood mechanisms [10,11], while the more efficient
GG immunization directly transfects cells by depositing
DNA-coated gold beads into the cytoplasm of antigen pre-
senting cells [12,13]. Some reports have claimed that the
route of DNA delivery has a major impact on the type of
immune responses induced by DNA vaccines, with GG
inducing Th-2 biased immune responses dominated by
IgG1 subclass antibodies and IM inducing Th-1 biased
responses dominated by IgG2a antibodies (9, 14, 15).
However, most studies of the effects of route of adminis-
tration for DNA vaccination have been performed with
viral antigens, and none have employed nematode anti-
gens. Therefore, the present study was designed to exam-
ine how the route of DNA delivery affects antibody
responses to filarial nematode antigens in mice. We also
examined the issue of whether antibody responses to indi-
vidual filarial antigens are affected when mice are injected
with a cocktail of plasmids encoding several antigens
(polyvalent DNA vaccination).
Methods
Selection of Recombinant Antigens and Preparation of 
Plasmid DNA for Immunization
Genes and partial genes for B. malayi paramyosin (BM5)
[16], intermediate filament (BMIF) [17], a heat-shock
protein (HSP-70) (GenBank number:AY383564), and an
antigen used for immune diagnosis (BM14) [18] were
chosen for immunization. Two eukaryotic expression vec-
tors, pJW4303 and pCR™3.1, were used for DNA vaccina-
tion. We have previously shown that both vectors were
capable of inducing immune responses to BM5 in mice
[6]. The same study showed that mice injected with these
vectors with no inserted gene sequences did not produce
antibodies to B. malayi antigens. For this reason, control
vaccinations with vector alone were not repeated in the
current study.
BM5, BMIF and HSP-70 were inserted into pJW4303 with
methods previously described in detail [6]. Briefly, cDNAs
were recovered from pBluescript by EcoRI digestion and
directly ligated into the EcoRI site of pJW4303, down-
stream from a tissue plasminogen signal peptide sequence
and upstream of a bovine growth hormone transcription
termination sequence. The cDNA of BM14 was produced
by PCR amplification with specific primers and directly
ligated into pCR™3.1 creating BM14/pCR3 recombinant
plasmid by methods previously described in detail [6].
The orientation and reading frame of all recombinant
plasmids were confirmed by DNA sequencing.
Plasmid DNA for injection was prepared using the Qiagen
Plasmid Maxikit (Hilder, Germany) according to the man-
ufacturer's instructions. The quantity and purity of iso-
lated plasmid DNA was assessed spectrophotometrically,
and the ratio of OD 260 to OD 280 of DNA preparations
used for immunization was > 1.8. Purified plasmid DNA
was dissolved in 10 mM Tris EDTA, pH 8.0, and diluted in
PBS to obtain a final concentration of 1 mg/ml for
injection.Filaria Journal 2004, 3 http://www.filariajournal.com/content/3/1/1
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Intramuscular and intradermal inoculation of DNA
For IM injection, a 1 cc insulin syringe with a 28 1/2-gauge
needle was used to inject mice with 50 µl of a 1 mg/ml
solution of plasmid DNA in PBS into quadriceps muscles
in both rear legs. For GG inoculation, DNA was precipi-
tated onto gold beads (1.0 µm) with a DNA loading ratio
of 10 µg/mg gold according to the manufacturer's instruc-
tions (Bio-Rad Laboratories, Hercules, CA). A helium
pulse gun (Bio-Rad) was used with discharge pressure of
250 psi to delivery 5 µg of plasmid DNA in a single shot
into freshly shaven abdominal skin for single antigens.
For some experiments, all four plasmids were combined,
and four nonoverlapping shots were administered with
the gene gun to deliver a total of 5 µg of each plasmid in
the cocktail.
Vaccination Protocol
Four-week-old female BALB/c mice were vaccinated with
100 µg plasmid DNA in PBS by IM injection or 5 µg plas-
mid DNA by GG at 0 and 4 wk. Sera were collected at 2, 6,
and 8 wk after the first immunization.
Antibody Assays
The proteins encoded by cDNAs used for DNA vaccina-
tion have been previously expressed in various expression
vectors and purified [5,16-18]. Antibody responses to
purified recombinant antigens (BM5/MBP, BMIF/GST,
BMHSP/His, BM14/His) were assessed in mice by ELISA.
Microtiter plates (Dynatech Technologies, Chantilly, VA)
coated with purified recombinant filarial antigens (2 µg/
ml in carbonate buffer, pH 9.6) were incubated with
mouse sera diluted 1/100 in PBS/T/FCS in duplicate wells
for 2 hr at 37°C. Bound antibody was detected after incu-
bation with peroxidase-conjugated goat anti-mouse IgG,
IgG1, or IgG2a antibodies (Southern Biotechnology Asso-
ciates, Birmingham, AL) for 1 hr at 37°C. Optical density
at 490 nm (OD) was read versus a PBS blank at 490 nm
with a Biotek 312e Micro plate ELISA reader. Sera that pro-
duced net OD values greater than the mean OD plus 3 SD
obtained with a panel of normal mouse sera were consid-
ered to have significant antibody responses.
IgG subclass ELISAs were normalized as previously
described (18). Briefly, microtiter plates were coated with
10 µg/ml of either purified IgG, IgG1 and IgG2a mouse
proteins (Southern Biotechnology Associates) overnight
at 4°C, and then incubated with serial dilution of goat
anti-mouse horseradish peroxidase (HRP)-conjugated
antibodies to total IgG, IgG1or IgG2a. The dilutions of
each anti-mouse IgG subclass antibody conjugates that
gave identical OD values in the ELISA were chosen for use
in assays of sera from vaccinated mice. Since IgG2a and
IgG1 have been used as indicators of the induction of Th1
and Th2 responses, respectively, the IgG1/IgG2a ratio can
help to define the T-cell phenotype induced by vaccina-
tion [19]. Thus, IgG1/IgG2a ratios were used as indicators
of Th1 or Th2 biased responses induced by plasmid DNA
after immunization by different routes (GG or IM).
Statistical analysis
The statistical significance of group differences in anti-
body responses was determined by the non-parametric
Kruskal-Wallis test. Differences were considered to be sta-
tistically significant when P < 0.05.
Results
Effect of Route of Immunization on Immune Responses in 
Mice
Mice produced IgG antibodies to all four of the recom-
binant antigens studied after DNA immunization by
either route. Intramuscular immunizations induced
stronger antibody responses in most mice, but GG immu-
nization induced more consistent antibody responses.
Results obtained with each antigen are presented below.
BM5 DNA Vaccination
Gene Gun DNA vaccination with BM5 yielded a mean
IgG1 to IgG2a ratio of > 10, signifying relatively more
IgG1 than IgG2a (Figure 1B). In contrast, IgG1 to IgG2a
ratios were < 1 in IM vaccinated mice, signifying more
IgG2a than IgG1. Overall, GG immunization with BM5
plasmid DNA produced a greater degree of isotype skew-
ing than IM vaccination (Figure 1A)
This figure shows serum IgG isotype antibody responses in  mice vaccinated with BM5 by intramuscular (IM) N = 7 and  Gene Gun (GG), N = 8 immunization Figure 1
This figure shows serum IgG isotype antibody responses in 
mice vaccinated with BM5 by intramuscular (IM) N = 7 and 
Gene Gun (GG), N = 8 immunization. Antigen-specific ELI-
SAs were performed with sera collected 8 wk after the first 
immunization. A: IgG1 and IgG2a results shown are mean 
OD + SE for IM and GG mice; B: IgG1 to IgG2a ratios are 
shown for mice immunized with BM5 by IM and GG routes. 
Values shown are mean PD +SE. The ratios in the two 
groups were significantly different (p < 0.05).
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BMIF DNA Vaccination
Mice immunized with BMIF antigen by either IM or GG
produced very similar levels of total IgG and IgG2a anti-
bodies to BMIF. Higher IgG1 antibody responses to BMIF
were observed in mice immunized by GG (Figure 2A), but
the ratios of IgG1 to IgG2a in GG and IM vaccinated mice
were not significantly different. The ratios of IgG1 to
IgG2a from IM and GG immunizations were > 1 (GG =
7.5, IM = 2.5) (Figure 2B), signifying more IgG1 than IgG2
in both groups. As observed after BM5 immunization, GG
immunization with BMIF DNA produced more pro-
nounced isotype skewing than IM vaccination (Figure
2A).
BMHP DNA Vaccination
Gene gun and IM DNA immunization with BMHSP
induced very similar IgG antibody response to BMHSP
with strong IgG2a responses and very weak IgG1
responses (Figure 3A). The ratios of IgG1 to IgG2a anti-
bodies were very low (< 0.3) after both GG and IM immu-
nization with DNA encoding this antigen (Figure 3B).
BM14 DNA Vaccination
Intramuscular and GG DNA immunization with BM14
antigen produced antibody isotype responses similar to
those observed after BMHSP vaccination, with stronger
IgG2a than IgG1 (IgG1/IgG2a < 0.5) (Figure 4B). How-
ever, IM vaccination induced stronger antibody responses,
with more total IgG and IgG1 antibodies to BM14 anti-
gen, than those produced by GG immunization (Figure
4A).
Antibody Responses to Plasmid Mixtures
The effect of mixing plasmids on DNA vaccination was
determined by examining antibody responses to antigens
encoded by plasmids combined in a four antigen DNA
cocktail vaccine. Most mice vaccinated with the plasmid
mixture produced IgG antibodies to each of the antigens
This figure shows serum IgG isotype antibody responses in  mice vaccinated with BMIF by IM (N = 12) and GG (N = 9) Figure 2
This figure shows serum IgG isotype antibody responses in 
mice vaccinated with BMIF by IM (N = 12) and GG (N = 9). 
Antigen-specific ELISAs were performed with sera collected 
8 wk after immunization. A: IgG1 and IgG2a antibodies 
shown are mean OD + SE; B: IgG1 to IgG2a ratios are 
shown for mice immunized with BMIF by IM and GG routes. 
Values shown are means + SE. The ratios were not signifi-
cantly different.
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This figure shows serum IgG isotype antibody responses in  mice vaccinated with BMHSP by IM (N = 12) and GG (N = 9)  route Figure 3
This figure shows serum IgG isotype antibody responses in 
mice vaccinated with BMHSP by IM (N = 12) and GG (N = 9) 
route. Antigen-specific ELISAs were performed with sera 
collected 8 wk after immunization. A: IgG1 and IgG2a results 
shown are mean OD +SE; B: IgG1 to IgG2a ratios are shown 
for mice immunized with BMHSP by IM and GG route. Val-
ues shown are means + SE. The ratios were not significantly 
different.
This figure shows serum IgG isotype antibody responses in  mice vaccinated with BM14 by IM (N = 12) and GG (N = 9) Figure 4
This figure shows serum IgG isotype antibody responses in 
mice vaccinated with BM14 by IM (N = 12) and GG (N = 9). 
Antigen-specific ELISAs were performed with sera collected 
8 wk after immunization.A: IgG, IgG1 and IgG2a antibody 
results shown are mean OD + SE; B: IgG1 to IgG2a antibody 
ratios are shown for mice immunized with BMHSP by IM and 
GG routes. Values shown are means + SE. The ratios were 
not significantly different.
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encoded by plasmids in the cocktail. Polyvalent vaccina-
tion did not significantly alter the isotype bias of antibody
responses to individual antigens (data not shown). Spe-
cific antibodies were detectable 2 wk after the first IM
injection in most cases, and antibody levels increased after
booster injections of plasmid DNA (Figure 5). Responses
to polyvalent vaccination by GG were similar, but these
took longer to develop (data not shown).
IgG antibody responses induced by the combination vac-
cine were compared to those obtained after injection with
single plasmid components of the combination vaccine.
However, polyvalent vaccination did not alter the isotype
bias of antibody responses to individual antigens (data
not shown). Antibody responses to three of the antigens
(BM5, BMIF and BM14) were weaker following cocktail
vaccination than after vaccination with single plasmids.
However, antibody responses to BMHSP were the same
after monovalent and polyvalent vaccination. Antibody
responses to BM14 were lower than those to other anti-
gens in the cocktail.
Discussion
Effect of Route of DNA Delivery on Antibody Responses to 
B. malayi Antigen(s) in Mice
One of the objectives of this work was to compare anti-
body responses induced by IM or GG immunization with
plasmids encoding several B. malayi antigens. Several fac-
tors have been reported to influence the strength and
nature of immune responses in mice after DNA
vaccination [20,21]. Prior reports have emphasized the
effects of routes and methods of DNA delivery as factors
that affect antibody responses because of differences in
efficiency of gene transfer and types of cells transfected
[9,15,22,23]. Early studies showed that IM injection
results in low-level transfection of myocytes [24], whereas
intradermal injection is believed to directly tranfect anti-
gen-presenting cells [25,26].
Our results showed that mice produced antibody
responses to target filarial antigens after DNA vaccination
by either IM or GG intradermal injection. Intramuscular
injection tended to induce stronger antibody responses.
However, the plasmid DNA dose was 20 times higher in
i.m. immunized mice. Therefore, GG induced higher anti-
body responses per unit plasmid DNA. Similar results
have been reported in mice immunized with other anti-
gens [15,25].
Apart from antibody levels, several studies have reported
that the route of DNA delivery can affect the protective
efficacy of DNA vaccines, which does not always correlate
with antibody titers. For example, DNA encoding a Plas-
modium yoelii antigen (HEP17) protected mice equally
well when given by the GG or IM routes, while DNA
encoding two other antigens (CSP and SSP2) induced bet-
ter protection by the IM route than by the GG route [27].
On the other hand, Leitner et al., reported that DNA
encoding CSP was protective in a different malaria model
only after GG vaccination [28]. Thus, neither route was
conclusively favored in all cases; different injection meth-
ods may provide optimal immunogenicity for different
antigens. Therefore, our results and the work of others
suggest that it is not possible to reliably predict the opti-
mal route for a given antigen to achieve desired immune
responses. There is currently no substitute for empirical
testing of each antigen.
Some prior studies have shown that GG vaccination tends
to induce helper T-cell responses of the Th2 phenotype
with a bias toward IgG1 antibody responses, while IM
injection of DNA tends to produce a Th1-phenotype with
a bias toward IgG2a [9,29]. In the present study, this pat-
tern was observed for only one of four antigens tested
(BM5). Other recombinant plasmids produced antibody
responses biased toward IgG1 or IgG2a independent of
route. These results suggest that the isotype profile of
antibodies generated by DNA immunization depends not
only on the route of DNA delivery but also on the intrinsic
nature of antigens used for immunization.
Antibody Responses to a Polyvalent DNA Vaccine
A second goal of our study was to compare antibody
responses induced by monovalent and polyvalent DNA
vaccines. One of the potential advantages of DNA vaccina-
tion is the ability to develop combination vaccines
Time course of total IgG antibodies to individual recom- binant B. malayi antigens after polyvalent and monovalent  DNA vaccination by IM injection Figure 5
Time course of total IgG antibodies to individual recom-
binant B. malayi antigens after polyvalent and monovalent 
DNA vaccination by IM injection. ELISAs were performed 
with sera collected at different times after immunization. 
Results shown are mean OD + SE. A: IgG antibody 
responses to individual antigens after polyvalent DNA vacci-
nation (5 mice). B: IgG antibody responses to individual anti-
gens after monovalent DNA vaccination (7 mice for BM5, 12 
mice for each of the other antigens).Filaria Journal 2004, 3 http://www.filariajournal.com/content/3/1/1
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consisting of multiple plasmids expressing different anti-
gens. Polyvalent vaccines may be needed to achieve high
levels of protection against complex pathogens like
helminth parasites. It is important, therefore, to deter-
mine whether co-injection of multiple plasmids success-
fully induces antibody to each component antigen
encoded by the plasmid mixture. We confirmed this to be
the case in mice injected with a cocktail of plasmids
encoding four B. malayi antigens. Total IgG antibody
responses to three of these antigens (BMIF, BM14 and
BMHP) tended to be weaker than those in mice injected
with single plasmids.
In conclusion, we have studied murine antibody
responses to four B. malayi antigens following DNA vacci-
nation by the IM and GG routes. Our results show that
antibody responses induced by DNA vaccines can be
affected by the route of injection and also by the intrinsic
nature of the antigens encoded. We also showed that a
tetravalent DNA vaccine induced antibodies to all four B.
malayi antigens encoded by the plasmids in the cocktail.
Although these findings represent progress, we realize that
much more work is needed before practical DNA vaccines
for filariasis become a reality. Our next priority will be to
determine whether the antigens employed in this study
(alone or in combination) have protective activity against
B. malayi in animals. In addition, more work is needed to
optimize vaccination protocols, and many other candi-
date antigens need to be tested. We believe these results
will be of interest to those working to develop DNA vac-
cines against complex pathogens such as filarial
nematodes.
Conclusions
The type of antibody responses induced by DNA vaccines
can be affected by the route of injection and also by the
intrinsic nature of antigens employed. Polyvalent DNA
vaccines can induce antibodies to each component
antigen.
List of abbreviations
IM intramuscular injection
GG Gene gun-intradermal inoculation
MF Microfilaria
BM5 Brugia malayi paramyosin
BMHSP-70 Brugia malayi 70 kDa heat shock protein
BMIF Brugia malayi intermediate filament
BM14 Brugia malayi serodiagnostic antigen
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